ADC Therapeutics SA Common Shares (ADCT)

Adc Therapeutics is a biotechnology company focused on the development of next-generation antibody-drug conjugates (ADCs) for the treatment of cancers

The company leverages its proprietary technology platform to create innovative therapies that specifically target and kill cancer cells while sparing healthy tissue, thereby enhancing treatment efficacy and reducing side effects. Adc Therapeutics aims to address unmet medical needs in oncology by advancing its pipeline of drug candidates through clinical trials, and its research efforts are guided by a commitment to improve patient outcomes in various types of malignancies.